Get started
Author

Yoshihito Nagura

Observed names: Nagura, Yoshihito, Yoshihito, Nagura
OpenAlex ID: A5003967732
The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis
2023 · Sho Matoya, Takanori Suzuki, et al. · Hepatology Research · 24
PDF
The first management using intubation of a nasogastric tube with Gastrografin enterography or long tube for non-strangulated acute small bowel obstruction: a multicenter, randomized controlled trial
2020 · Takahito Katano, Takaya Shimura, et al. · Journal of Gastroenterology · 17
Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection
2021 · Takanori Suzuki, Kentaro Matsuura, et al. · PLoS ONE · 13
PDF
Long‐term outcomes of nasogastric tube with Gastrografin for adhesive small bowel obstruction
2021 · Hirotada Nishie, Takaya Shimura, et al. · Journal of Gastroenterology and Hepatology · 12
Serum interleukin‐6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis
2024 · Takanori Suzuki, Kentaro Matsuura, et al. · Journal of Gastroenterology and Hepatology · 11
PDF
Percutaneous Transhepatic Self-expanding Metallic Stent Placement for the Treatment of Malignant Afferent Loop Obstruction
2017 · Naruomi Jinno, Itaru Naitoh, et al. · Internal Medicine · 11
PDF
Serum angiopoietin‐2 levels predict regression of Mac‐2 binding protein glycosylation isomer‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents
2022 · Takanori Suzuki, Kentaro Matsuura, et al. · Hepatology Research · 9
Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B
2022 · Yoshihito Nagura, Kentaro Matsuura, et al. · PLoS ONE · 9
PDF
A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C
2021 · Masanori Atsukawa, Akihito Tsubota, et al. · PLoS ONE · 9
PDF
Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study
2024 · Takanori Suzuki, Kentaro Matsuura, et al. · Oncology · 8
Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis
2023 · Takanori Suzuki, Kentaro Matsuura, et al. · Cancer Medicine · 7
PDF
Serum inducible protein 10 kDa/C‐X‐C motif chemokine 10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents
2023 · Yoshihito Nagura, Takanori Suzuki, et al. · Hepatology Research · 7
PDF
Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlapping Syndrome Complicated by Ulcerative Colitis
2022 · Takanori Suzuki, Itaru Naitoh, et al. · Internal Medicine · 4
PDF
Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents
2024 · Takanori Suzuki, Kentaro Matsuura, et al. · Oncology · 3
Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation
2022 · Takanori Suzuki, Kentaro Matsuura, et al. · Hepatology Research · 3
PDF
Novel Genetic Rearrangements Termed “Structural Variation Polymorphisms“ Contribute to the Genetic Diversity of Orthohepadnaviruses
2019 · Kei Fujiwara, Kentaro Matsuura, et al. · Viruses · 3
PDF
MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents
2024 · Takanori Suzuki, Kentaro Matsuura, et al. · Journal of Gastroenterology · 2
Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study
2024 · Daisuke Kato, Takanori Suzuki, et al. · Oncology · 1
Adult-onset Still's Disease (AOSD) with Gastrointestinal Lesions
2024 · Takahito Harada, Yoshikazu Hirata, et al. · Internal Medicine · 1
PDF
A case with relapsed Fanconi syndrome due to administration of tenofovir alafenamide for chronic hepatitis B
2023 · Takanori Suzuki, Kentaro Matsuura, et al. · Kanzo · 1
PDF
Efficacy of minocycline hydrochloride aspiration sclerotherapy with additional monoethanolamine oleate aspiration sclerotherapy for symptomatic hepatic cysts
2022 · Yoshihide Kimura, Kei Fujiwara, et al. · Hepatology Research · 1
PDF
Complex structural variations in non-human primate hepatitis B virus
2021 · Yoshihito Nagura, Kei Fujiwara, et al. · Virology Journal · 1
PDF
Serum miR-192-5p Levels Predict the Efficacy of Pegylated Interferon Therapy for Chronic Hepatitis B<Abstract of dissertation>
· Yoshihito, Nagura · Institutional Repositories DataBase (IRDB)
Works count: 25
Citation count: 157
H-index: 9
I10-index: 6
Year
Topic
Type